DR. ROBERT BRIAN BERRYMAN M.D. NPI 1871535823

NPI Details

DR. Robert Brian Berryman, M.D. is a medical oncology internal medicine in Dallas, TX with 32 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Robert Brian Berryman, M.D. NPI is 1871535823. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1994

The provider's business location address is:

3410 WORTH ST STE 300
DALLAS, TX
ZIP 75246-012
Phone: (214) 370-1513
Fax: (214) 370-1585

The NPI 1871535823 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, daratumumab, 10 mg (HCPCS:J9145)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of vaccine, each additional vaccine (HCPCS:90472)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Unclassified drugs (HCPCS:J3490)
• Injection of drug or substance into vein (HCPCS:96374)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Hepatitis b vaccine, adult dosage (3 dose schedule) (HCPCS:90746)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Administration of vaccine (HCPCS:90471)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Albumin (protein) level (HCPCS:82040)
• Bilirubin level, total (HCPCS:82247)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Total protein level, blood (HCPCS:84155)
• Liver enzyme (sgot), level (HCPCS:84450)
• Injection, fentanyl citrate, 0.1 mg (HCPCS:J3010)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Ferritin (blood protein) level (HCPCS:82728)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of hepatitis b vaccine (HCPCS:G0010)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 6/12/2006 and was last updated on 9/22/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.